• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与潜伏期不同,回避实验中的选择测量表明,加压素和催产素不会影响大鼠的记忆。

Choice, as opposed to latency, measures in avoidance suggest that vasopressin and oxytocin do not affect memory in rats.

作者信息

Sahgal A, Wright C

出版信息

Neurosci Lett. 1984 Aug 10;48(3):299-304. doi: 10.1016/0304-3940(84)90054-5.

DOI:10.1016/0304-3940(84)90054-5
PMID:6483287
Abstract

Latency measures from passive avoidance studies are frequently used as an index of memory. Thus, vasopressin (VP) is thought to enhance memory, since it has been shown to increase re-entry latencies. Conversely, several substances, such as oxytocin (OT), are supposed to have amnestic effects since they may decrease latencies. We describe a novel avoidance design, which allows latency to be assessed, but also permits the animal to re-enter into a distinctive compartment where shock had not been experienced (choice measure). Latency scores indicated that VP may improve memory, but the choice index suggested that this was not the case.

摘要

来自被动回避研究的潜伏期测量常常被用作记忆指标。因此,血管加压素(VP)被认为可增强记忆,因为已证明它能增加再次进入潜伏期。相反,几种物质,如催产素(OT),被认为具有遗忘作用,因为它们可能会缩短潜伏期。我们描述了一种新颖的回避设计,它既能评估潜伏期,又能让动物再次进入一个未经历电击的独特隔室(选择测量)。潜伏期分数表明VP可能改善记忆,但选择指数表明情况并非如此。

相似文献

1
Choice, as opposed to latency, measures in avoidance suggest that vasopressin and oxytocin do not affect memory in rats.与潜伏期不同,回避实验中的选择测量表明,加压素和催产素不会影响大鼠的记忆。
Neurosci Lett. 1984 Aug 10;48(3):299-304. doi: 10.1016/0304-3940(84)90054-5.
2
Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.单次注射催产素或加压素及其与两种选择性受体拮抗剂的相互作用对小鼠记忆存储的影响。
Neurobiol Learn Mem. 1998 Mar;69(2):136-46. doi: 10.1006/nlme.1997.3817.
3
Vasopressin, oxytocin and memory: effects on consolidation and retrieval processes.
Acta Psychiatr Belg. 1980 Sep-Oct;80(5):714-20.
4
Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes.催产素、加压素与记忆:对巩固和提取过程的相反作用。
Brain Res. 1978 Nov 24;157(2):414-7. doi: 10.1016/0006-8993(78)90052-5.
5
Expansion of vasopressin/oxytocin memory research I: peripheral administration.加压素/催产素记忆研究的拓展I:外周给药
Adv Pharmacol. 2004;50:339-88, 655-708. doi: 10.1016/S1054-3589(04)50009-1.
6
Passive avoidance behavior: opposite effects of oxytocin analogs with agonist and antagonist properties.被动回避行为:具有激动剂和拮抗剂特性的催产素类似物的相反作用。
Regul Pept. 1981 Sep;2(5):285-91. doi: 10.1016/0167-0115(81)90033-1.
7
Opposite action of oxytocin to vasopressin in passive avoidance behavior in rats.催产素与加压素在大鼠被动回避行为中的相反作用。
Physiol Behav. 1978 Jun;20(6):801-2. doi: 10.1016/0031-9384(78)90309-8.
8
Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.血管加压素和催产素C末端片段对大鼠回避行为的构效关系研究。
J Pharmacol Exp Ther. 1987 Apr;241(1):268-74.
9
Failure of vasopressin to enhance memory in a passive avoidance task in rats.
Neurosci Lett. 1982 Jan 22;28(1):87-92. doi: 10.1016/0304-3940(82)90213-0.
10
An inability of subcutaneous vasopressin to affect passive avoidance behavior.皮下注射加压素无法影响被动回避行为。
Neuroendocrinology. 1980;30(3):174-7. doi: 10.1159/000122995.

引用本文的文献

1
A critique of the vasopressin-memory hypothesis.对血管加压素-记忆假说的批判。
Psychopharmacology (Berl). 1984;83(3):215-28. doi: 10.1007/BF00464785.
2
Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.血管加压素、去甘氨酰胺血管加压素和苯丙胺对被动与主动联合回避任务的影响。
Psychopharmacology (Berl). 1986;90(4):494-8. doi: 10.1007/BF00174067.
3
Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.去氨基-D-精氨酸加压素(DDAVP)与乙醇不同,对人类枯燥的视觉警觉任务没有影响。
Psychopharmacology (Berl). 1986;90(1):58-63. doi: 10.1007/BF00172872.